Glutathione in Clinical Practice: Evidence and Applications

Glutathione (GSH) is a tripeptide (γ-glutamyl-cysteinyl-glycine) present in virtually every cell of the human body. As the most abundant intracellular antioxidant, it plays a central role in neutralising reactive oxygen species, supporting detoxification pathways, and maintaining cellular redox balance. Clinical interest in glutathione supplementation has grown substantially, particularly in aesthetic medicine and longevity clinics.

Endogenous Role and Age-Related Decline

Glutathione exists in two forms: reduced (GSH, the active form) and oxidised (GSSG). A high GSH:GSSG ratio is indicative of healthy cellular function. With aging, glutathione levels decline and the GSH:GSSG ratio shifts unfavourably. Sekhar et al. (2011), publishing in The American Journal of Clinical Nutrition, demonstrated that glutathione deficiency in elderly subjects was associated with increased oxidative stress and that supplementation with glutathione precursors (glycine and cysteine) restored GSH levels and reduced markers of oxidative damage.

Oral vs Parenteral Bioavailability

Oral glutathione bioavailability has been debated. The tripeptide is subject to hydrolysis by intestinal gamma-glutamyltransferase and dipeptidases, limiting the amount of intact GSH reaching systemic circulation. While some studies have shown modest benefits with oral supplementation, parenteral routes (IV or IM) bypass these limitations entirely.

Intravenous glutathione administration delivers the compound directly to the bloodstream, achieving plasma concentrations that are not attainable through oral supplementation. This has made IV glutathione a staple in integrative and aesthetic medicine clinics.

Evidence in Skin Health

A randomised, double-blind, placebo-controlled trial by Weschawalit et al. (2017), published in Clinical, Cosmetic and Investigational Dermatology, evaluated the effects of glutathione supplementation on skin properties. The study found that glutathione supplementation (both oral and sublingual) produced measurable improvements in skin elasticity and reductions in wrinkle formation compared to placebo.

Glutathione's skin-lightening properties are attributed to its ability to inhibit tyrosinase (the rate-limiting enzyme in melanin synthesis) and to shift melanin production from eumelanin (dark pigment) to phaeomelanin (lighter pigment). These effects have been documented across multiple clinical studies.

Detoxification and Hepatoprotection

Glutathione is a critical cofactor in hepatic phase II conjugation reactions, facilitating the detoxification and excretion of drugs, heavy metals, and other xenobiotics. Honda et al. (2017), in a study published in BMC Gastroenterology, demonstrated that IV glutathione therapy improved markers of liver function in patients with non-alcoholic fatty liver disease (NAFLD).